nih-funding-support_reduced-size-1024x683

BioVinc Awarded SBIR Phase II Grant by NIH/NIAID to Advance Novel Treatment for Prosthetic Joint Infections

BioVinc is proud to announce that it has received a multi-million prestigious SBIR Phase II grant from the National Institutes of Health (NIH/NIAID). This grant will accelerate our efforts in the research and development of new treatments targeting the significant unmet medical need of prosthetic joint infections. Deep bone infections, such as prosthetic joint infections,…

Holiday Discounts

Happy Holidays from the Biovinc family to yours. For the month of December 2019, BioVinc is pleased to provide all customers with a special 10% discount on all sales. Please use coupon code THANKYOU2019 at check out. For all returning customers, please email inquiry@biovinc.com for a further discount for the remainder of 2019. We look…

nih-funding-support_reduced-size-1024x683

BioVinc Receives an STTR Phase II Grant from NIH

BioVinc Receives an STTR Phase II Grant from the National Institutes of Health BioVinc is pleased to announce that its research team has been awarded an STTR Phase II grant from the National Institutes of Health (NIH/NIDCR). This grant will support a highly promising collaboration with Dr. Parish P. Sedghizadeh at the University of Southern…